AGIO
Price
$39.05
Change
-$0.48 (-1.21%)
Updated
Jul 11 closing price
Capitalization
2.26B
19 days until earnings call
NTLA
Price
$11.54
Change
-$0.63 (-5.18%)
Updated
Jul 11 closing price
Capitalization
1.19B
19 days until earnings call
Interact to see
Advertisement

AGIO vs NTLA

Header iconAGIO vs NTLA Comparison
Open Charts AGIO vs NTLABanner chart's image
Agios Pharmaceuticals
Price$39.05
Change-$0.48 (-1.21%)
Volume$793.6K
Capitalization2.26B
Intellia Therapeutics
Price$11.54
Change-$0.63 (-5.18%)
Volume$3.73M
Capitalization1.19B
AGIO vs NTLA Comparison Chart in %
Loading...
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGIO vs. NTLA commentary
Jul 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGIO is a StrongBuy and NTLA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 12, 2025
Stock price -- (AGIO: $39.05 vs. NTLA: $11.53)
Brand notoriety: AGIO and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGIO: 128% vs. NTLA: 73%
Market capitalization -- AGIO: $2.26B vs. NTLA: $1.19B
AGIO [@Biotechnology] is valued at $2.26B. NTLA’s [@Biotechnology] market capitalization is $1.19B. The market cap for tickers in the [@Biotechnology] industry ranges from $318.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGIO’s FA Score shows that 1 FA rating(s) are green whileNTLA’s FA Score has 1 green FA rating(s).

  • AGIO’s FA Score: 1 green, 4 red.
  • NTLA’s FA Score: 1 green, 4 red.
According to our system of comparison, AGIO is a better buy in the long-term than NTLA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGIO’s TA Score shows that 4 TA indicator(s) are bullish while NTLA’s TA Score has 6 bullish TA indicator(s).

  • AGIO’s TA Score: 4 bullish, 4 bearish.
  • NTLA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, NTLA is a better buy in the short-term than AGIO.

Price Growth

AGIO (@Biotechnology) experienced а +8.26% price change this week, while NTLA (@Biotechnology) price change was +7.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.14%. For the same industry, the average monthly price growth was +16.46%, and the average quarterly price growth was +20.75%.

Reported Earning Dates

AGIO is expected to report earnings on Oct 30, 2025.

NTLA is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+9.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AGIO($2.26B) has a higher market cap than NTLA($1.2B). AGIO YTD gains are higher at: 18.837 vs. NTLA (-1.072). AGIO has higher annual earnings (EBITDA): -434.71M vs. NTLA (-530.8M). AGIO has more cash in the bank: 893M vs. NTLA (504M). AGIO has less debt than NTLA: AGIO (52.9M) vs NTLA (119M). NTLA has higher revenues than AGIO: NTLA (45.6M) vs AGIO (37M).
AGIONTLAAGIO / NTLA
Capitalization2.26B1.2B189%
EBITDA-434.71M-530.8M82%
Gain YTD18.837-1.072-1,757%
P/E Ratio3.38N/A-
Revenue37M45.6M81%
Total Cash893M504M177%
Total Debt52.9M119M44%
FUNDAMENTALS RATINGS
AGIO vs NTLA: Fundamental Ratings
AGIO
NTLA
OUTLOOK RATING
1..100
1517
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
29
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
1797
PRICE GROWTH RATING
1..100
4238
P/E GROWTH RATING
1..100
69100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NTLA's Valuation (29) in the Biotechnology industry is in the same range as AGIO (43). This means that NTLA’s stock grew similarly to AGIO’s over the last 12 months.

NTLA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as AGIO (100). This means that NTLA’s stock grew similarly to AGIO’s over the last 12 months.

AGIO's SMR Rating (17) in the Biotechnology industry is significantly better than the same rating for NTLA (97). This means that AGIO’s stock grew significantly faster than NTLA’s over the last 12 months.

NTLA's Price Growth Rating (38) in the Biotechnology industry is in the same range as AGIO (42). This means that NTLA’s stock grew similarly to AGIO’s over the last 12 months.

AGIO's P/E Growth Rating (69) in the Biotechnology industry is in the same range as NTLA (100). This means that AGIO’s stock grew similarly to NTLA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGIONTLA
RSI
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 12 days ago
76%
Bearish Trend 12 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WSMVX26.99N/A
N/A
Wilshire Small Company Value Instl
DRDAX26.13N/A
N/A
Dearborn Partners Rising Dividend A
LGLFX53.01N/A
N/A
Lord Abbett Growth Leaders F
CLVRX34.79N/A
N/A
Calvert US Large Cap Value Rspnb Idx R6
BLYAX33.92-0.23
-0.67%
American Beacon Man Lg Cp Growth A

AGIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, AGIO has been loosely correlated with LGND. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if AGIO jumps, then LGND could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGIO
1D Price
Change %
AGIO100%
-1.21%
LGND - AGIO
53%
Loosely correlated
-2.62%
ZYME - AGIO
49%
Loosely correlated
-2.34%
CRNX - AGIO
46%
Loosely correlated
-0.19%
KRYS - AGIO
46%
Loosely correlated
-1.05%
VRDN - AGIO
46%
Loosely correlated
-0.53%
More